Where is Atbpharma located?

Atbpharma is headquartered in Serbia.

Is Atbpharma a funded company?

Atbpharma is a funded company, having raised an undisclosed amount across 11 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 05, 2023.

When was the latest funding round of Atbpharma?

Atbpharma's latest funding was a $***** Grant (prize money) round on Mar 21, 2024, with participation from 1 investor.

Where does Atbpharma rank among its competitors?

Atbpharma ranks 947th amongst 2104 active competitors, of which 117 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Atbpharma?

Atbpharma's top competitors include AbbVie, Merck and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Atbpharma - 2026 Company Profile, Funding & Competitors

Company Details

Manufacturer of pharmaceuticals and dietary supplements. This company produces a range of prescription and over-the-counter medications, encompassing various therapeutic areas. In addition, it offers a line of dietary supplements designed to support overall health and well-being, addressing specific needs such as joint health, cardiovascular support, and stress management. The manufacturing process adheres to stringent quality control standards.

Website: atbpharma.rs
Social

Key Metrics

Location

Serbia

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Mar 21, 2024, $*****

Investors

Ministerstvo Hospodárstva Slovenskej Republiky

Ranked

947^th among 2104 active competitors

Similar Companies

AbbVie & 2134 more

View Atbpharma's full profile

Atbpharma has raised funding over 11 rounds. Its first funding round was on May 05, 2023. Its latest funding round was a Grant (prize money) round on Mar 21, 2024 for $*****. 1 investor participated in its latest round. Atbpharma has 1 institutional investor.

Here is the list of recent funding rounds of Atbpharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2024	4823373	Grant (prize money)	8302383	7457945	7624888	9007838
Mar 01, 2024	5958506	Grant (prize money)	7961983	4292374	7148931	Ministerstvo Hospodárstva Slovenskej Republiky
Dec 22, 2023	8344994	Grant (prize money)	8861325	2480419	3867907	Ministerstvo Hospodárstva Slovenskej Republiky

Access funding benchmarks and valuations. Sign up today!

View details of Atbpharma's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Atbpharma include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of Atbpharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	84/100
2nd	Merck 1891, Rahway (United States), Public	Manufacturer of pharmaceutical products	-	Bill & Melinda Gates Foundation, Berkshire Hathaway ... & 11 others	83/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 18 others	82/100
4th	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	80/100
5th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	77/100
6th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	76/100
7th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 17 others	76/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	72/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 12 others	71/100
10th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Berkshire Hathaway, Alcor Fund & 16 others	71/100
947th	Atbpharma Serbia, Funding Raised	Manufacturer of pharmaceuticals and dietary supplements	-	Ministerstvo Hospodárstva Slovenskej Republiky	18/100